Chapter 44- Pregnancy and Lactation: Therapeutic Considerations

Description:
IMPORTANT NOTE – PLEASE READ FIRST: This continuing education assessment requires that you first purchase the text book: Pharmacotherapy Principles & Practice. Please go to our home page: http://www.rxugace.com/ and click on “Books” for more information Prior To Registering for this assessment.

Upon completion of the corresponding textbook chapter in Pharmacotherapy Principles & Practice and this on-line assessment, the reader should be able to:

1. Identify the stages of fetal development when birth defects are most likely to occur.
2. Describe hormonal regulation of lactation.
3. Determine trimesters and a due date for a pregnancy based on the last menstrual period.
4. List routine pregnancy care and screenings that should be provided for women with uncomplicated pregnancies.
5. Discuss characteristics that affect drug transfer across the placental barrier and into breast milk.
6. Discuss general methods by which teratogenic risk and drug exposure during pregnancy and lactation can be minimized.
7. Identify drugs whose use should be strictly avoided in pregnancy or lactation.
8. Recommend nonpharmacologic therapy for the following disorders when they occur during pregnancy or lactation: nausea and vomiting, constipation, heartburn, pain, and cough and cold.
9. Recommend an appropriate dose and formulation of folic acid to a woman desiring to become pregnant.
10. Recommend a pharmacotherapy regimen that is likely to minimize risk to the fetus or baby for the following disorders that are commonly experienced during pregnancy: nausea and vomiting, constipation, hemorrhoids, heartburn, pain, and upper respiratory symptoms.
11. Recommend a pharmacotherapy regimen for asymptomatic bacteriuria in a pregnant female that is likely to be safe and effective.
12. Recommend treatment (including drug selection, dosing, monitoring, and alternative treatments) for bacterial vaginosis, vulvovaginal candidiasis, and sexually transmitted diseases in a pregnant female based on guidelines from the Centers for Disease Control and Prevention.
13. Recommend a pharmacotherapy regimen for preterm labor that will prolong time to delivery and enhance fetal lung development while minimizing maternal side effects.
14. Recommend treatment (including drug selection, dosing, monitoring, and alternative treatments) for group B Streptococcus based on guidelines of the Centers for Disease Control and Prevention.
15. Recommend treatment (including drug selection, dosing, monitoring, and alternative treatments) for induction of labor.
16. Recommend a pharmacotherapy regimen that is likely to minimize risk to the infant for the following disorders experienced during lactation: acute mastitis, nipple candidiasis, and insufficient milk production.

Courses Offered